Participants 72 254 6
140 patients with a threatening premature birth at the greater than or equal to 24-less than 37 week of gestation were in this study randomly treated with hexoprenalin or salbutamol.
Participants 258 379 4
77% in the hexoprenalin and in 74% in the salbutamol group the weight of the newborn was greater than or equal to 2500 g.
Participants 598 715 5
11% of the mothers in the hexoprenalin group had side-effects during infusion compared to 30% in the salbutamol group
